Nature Communications (Mar 2022)

Thermosensitive hydrogel releasing nitric oxide donor and anti-CTLA-4 micelles for anti-tumor immunotherapy

  • Jihoon Kim,
  • David M. Francis,
  • Lauren F. Sestito,
  • Paul A. Archer,
  • Margaret P. Manspeaker,
  • Meghan J. O’Melia,
  • Susan N. Thomas

DOI
https://doi.org/10.1038/s41467-022-29121-x
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 13

Abstract

Read online

Nitric oxide exerts a multitude of physiological functions and has also been exploited for anticancer therapies. Here the authors report the design of a micelle-releasing thermosensitive hydrogel system for the concomitant locoregional and lymphatic delivery of a nitric oxide donor and an anti-CTLA4 antibody, showing anti-tumor immune responses in preclinical cancer models.